Berger Montague PC Investigating Claims on Behalf of...
Investigation Deadline:
September 21, 2026
featured news
March 19, 2014
General
Florida Pain Clinic to Pay $750,000 Amid Allegations of Phony Medicare Invoices
In a tale as old as time, another physician’s office has opted to settle with the federal government after facing allegations of fraudulent Medicare billing. Under the False Claims Act, it is considered unlawful for a doctor to submit invoices for repayment to healthcare agencies like Medicare or Medicaid for […]
March 18, 2014
General
$85 Million Settlement in Stark Law Whistleblower Case, Relator to Receive $20.8 Million
The federal Stark Law is designed to place limitations on physician referrals and to create greater patient confidence in the underlying rationale for a patient referral. Prior to the Stark Law, there were no regulations in place regarding referrals by a physician to laboratories or hospitals in which the physician […]
March 17, 2014
General
Recent False Claims Act Case Against Sprint Brings Wiretapping to the Forefront
The False Claims Act is used to address issues of overcharging the government for services rendered by independent, private contractors. In a recent case involving popular wireless provider Sprint, whistleblowers have alleged significant overcharges in conjunction with a contract to provide wiretapping services to federal agencies including the FBI, U.S. […]
March 14, 2014
General
Long Island Radiologist to Pay Over $15 Million to Settle False Claims Act Allegations
Fraud in the healthcare industry is reaching alarming levels. Each year, the Department of Justice works in concert with several other federal agencies and state-level counterparts to combat this growing trend. The False Claims Act is extremely pivotal in bringing healthcare fraud to light. Given the widespread problem of fraud […]
March 13, 2014
General
U.S. Solicitor General Explains the Inapplicability of Rule 9(b) in the False Claims Act
As we reported yesterday, the U.S. Solicitor General, upon request by the Supreme Court, submitted its amicus curiae brief in the hotly-contested False Claims Act case Nathan v. Takeda Pharmaceuticals. As a bit of background, this case involves the practice of off-label marketing, which occurs when a drug company promotes […]featured investigations
$2.4B+
in 2025 post-trial judgments
$55B+
in Settlements & Verdicts
55+
Years of Experience With High-Profile Cases
100+
Attorneys Protecting Your Rights
20+
Years Ranked as Top Law Firm by Chambers USA
50
States in Which The Firm Has Successfully Litigated
